胃癌肿瘤浸润深度的预测:CT影像组学的潜在价值
本研究回顾性纳入244例经病理证实的胃癌患者,分为训练队列171例和测试队列73例,利用术前动脉期和门静脉期增强CT提取影像组学特征并以随机森林建模,动脉期模型在训练队列和测试队列的AUC分别为0.899(95%CI 0.812-0.955)和0.825(95%CI 0.718-0.904),门静脉期模型AUC分别为0.843(95%CI 0.746-0.914)和0.818(95%CI 0.711-0.899),提示CT影像组学在区分T2与T3/4期胃癌方面有潜在价值。
要点
- 动脉期影像组学模型区分T2与T3/4期胃癌的AUC在训练队列为0.899、测试队列为0.825。
- 门静脉期影像组学模型区分T2与T3/4期胃癌的AUC在训练队列为0.843、测试队列为0.818。
- 单期相影像组学模型对T2与T3/4期胃癌的区分均表现良好。
诊断标准与关键数值
- 动脉期影像组学模型区分T2与T3/4期胃癌的AUC在训练队列为0.899(95%CI 0.812-0.955),在测试队列为0.825(95%CI 0.718-0.904)。
- 门静脉期影像组学模型区分T2与T3/4期胃癌的AUC在训练队列为0.843(95%CI 0.746-0.914),在测试队列为0.818(95%CI 0.711-0.899)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The aim of this study was to investigate the value of computed tomography (CT) radiomics for the differentiation between T2 and T3/4 stage lesions in gastric cancer.
MATERIALS AND METHODS: A total of 244 consecutive patients with pathologically proven gastric cancer were retrospectively included and split into a training cohort (171 patients) and a test cohort (73 patients). Preoperative arterial phase and portal phase contrast enhanced CT images were retrieved for tumor segmentation and feature extraction by using a dedicated postprocessing software. The random forest method was used to build the classifier models.
RESULTS: The performance of single phase radiomics models were favorable in the differentiation between T2 and T3/4 stage tumors. Arterial phase-based radiomics model exhibited areas under the curve of 0.899 (95% CI: 0.812-0.955) in the training cohort and 0.825 (95% CI: 0.718-0.904) in the test cohort. Portal phase-based radiomics model showed areas under the curve of 0.843 (95% CI: 0.746-0.914) and 0.818 (95% CI: 0.711-0.899) in the training and test cohort, respectively.
CONCLUSION: CT radiomics approach has a potential role in differentiation between T2 and T3/4 stage tumors in gastric cancer.
引用
- Wang Y, Liu W, Yu Y, et al. Prediction of the Depth of Tumor Invasion in Gastric Cancer: Potential Role of CT Radiomics. Acad Radiol. 2019. PMID: 31761666. doi:10.1016/j.acra.2019.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。